Indegene and Datavant partner to boost clinical trial recruitment
Indegene Limited announced a strategic partnership with Datavant on September 19, 2025, focused on enhancing patient recruitment for clinical trials. This collaboration aims to accelerate enrollment, reduce screen failures, and improve recruitment efficiency for biopharmaceutical organizations, especially in rare and complex disease studies. The partnership integrates Datavant's data enrichment capabilities into Indegene's NEXT Patient Recruitment platform.
Datavant, a data collaboration platform in healthcare, operates a health data retrieval network spanning over 80,000 hospitals and clinics and processing more than 100 million patient records annually. This extensive network, combined with Indegene's digital solutions, is expected to streamline the identification of suitable participants based on specific health data criteria.
The alliance is designed to provide eligible participants with opportunities to connect with trials tailored to their health conditions, leading to more informed decision-making and improved screen-to-randomization ratios for biopharma companies.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Indegene publishes news
Free account required • Unsubscribe anytime